Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping

Magnetic Resonance Imaging

Volumn 29, Issue 5, 2011, Pages 650-658

  Kirschner, Robert ^a,b,c   Varga Szemes, Akos ^a,b,c   Brott, Brigitta C ^d   Litovsky, Silvio ^e   Elgavish, Ada ^c,f   Elgavish, Gabriel A ^a,c   Simor, Tamas ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Elgavish Paramagnetics Inc   (United States)

^d University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

Cardiac MRI; Delayed enhancement; Histology; MRI contrast agent; Myocardial infarct; Myocardial viability

Indexed keywords

GADOLINIUM PENTETATE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG DISTRIBUTION; HEART INFARCTION; HEART INFARCTION SIZE; HISTOPATHOLOGY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE STUDY; REPERFUSION INJURY; SIGNAL DETECTION; SWINE; TISSUE DISTRIBUTION;

ALGORITHMS; ANGIOPLASTY, BALLOON; ANIMALS; CONTRAST MEDIA; CORONARY VESSELS; GADOLINIUM DTPA; HEART VENTRICLES; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; MYOCARDIUM; REPERFUSION; SWINE; TETRAZOLIUM SALTS; TIME FACTORS;

ANIMALIA; SUS;

EID: 79956154988     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.02.010     Document Type: Article

References (29)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart Disease and Stroke Statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117(4):e25-e146. Writing Group M.
2. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343(20):1445-1453.
3. Haas F., Haehnel C., Picker W., Nekolla S., Martinoff S., Meisner H., et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997, 30(7):1693-1700.
4. Setser R., Bexell D., O'Donnell T., Stillman A., Lieber M., Schoenhagen P., et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2003, 18(4):434-441.
5. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100(19):1992-2002.
6. Fieno D.S., Kim R.J., Chen E.L., Lomasney J.W., Klocke F.J., Judd R.M. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000, 36(6):1985-1991.
7. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002, 106(9):1083-1089.
8. Bondarenko O., Beek A.M., Hofman M.B.M., Kühl H.P., Twisk J.W.R., van Dockum W.G., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Res 2005, 7(2):481-485.
9. Ashikaga H., Sasano T., Dong J., Zviman M.M., Evers R., Hopenfeld B., et al. Magnetic resonance based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res 2007, 101(9):939-947.
10. Beek A., Kuhl H., Bondarenko O., Twisk J., Hofman M., van Dockum W., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003, 42(5):895-901.
11. Beek A.M., Bondarenko O., Afsharzada F., van Rossum A.C. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Res 2009, 11(1):6.
12. Ibrahim T., Nekolla S.G., Hornke M., Bulow H.P., Dirschinger J., Schomig A., et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005, 45(4):544-552.
13. Amado L.C., Gerber B.L., Gupta S.N., Rettmann D.W., Szarf G., Schock R., et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004, 44(12):2383-2389.
14. Hsu L.Y., Natanzon A., Kellman P., Hirsch G.A., Aletras A.H., Arai A.E. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006, 23(3):298-308.
15. El Berbari R., Kachenoura N., Frouin F., Herment A., Mousseaux E., Bloch I. An automated quantification of the transmural myocardial infarct extent using cardiac DE-MR images 2009, 4403-4406.
16. Wetstein L., Mark R., Kaplinsky E., Mitamura H., Kaplan A., Sauermelch C., et al. Histopathologic factors conducive to experimental ventricular tachycardia. Surgery 1985, 98(3):532-539.
17. Karagueuzian H.S., Fenoglio J.J., Weiss M.B., Wit A.L. Protracted ventricular tachcardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. Circ Res 1979, 44(6):833-846.
18. Schuleri K.H., Centola M., George R.T., Amado L.C., Evers K.S., Kitagawa K., et al. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2009, 53(18):1699-1707.
19. Suranyi P., Kiss P., Brott B.C., Simor T., Elgavish A., Ruzsics B., et al. Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution. Magn Reson Med 2006, 56(3):535-545.
20. Saab-Ismail N.H., Simor T., Gaszner B., Lorand T., Szollosy M., Elgavish G.A. Synthesis and in vivo evaluation of new contrast agents for cardiac MRI. J Med Chem 1999, 42(15):2852-2861.
21. Simor T., Gaszner B., Oshinski J., Waldrop S., Pettigrew R., Horvath I., et al. Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart. J Magn Reson Imaging 2005, 21(5):536-545.
22. Ruzsics B., Surányi P., Kiss P., Brott B., Elgavish A., Saab-Ismail N., et al. Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs. Pharmacology 2006, 77(4):188-194.
23. Kiss P., Suranyi P., Simor T., Saab-Ismail N.H., Elgavish A., Hejjel L., et al. In vivo R1-enhancement mapping of canine myocardium using ceMRI with Gd(ABE-DTTA) in an acute ischemia-reperfusion model. J Magn Reson Imaging 2006, 24(3):571-579.
24. Suranyi P., Kiss P., Ruzsics B., Brott B.C., Simor T., Elgavish A., et al. In vivo myocardial tissue kinetics of Gd(ABE-DTTA), a tissue-persistent contrast agent. Magn Reson Med 2007, 58(1):55-64.
25. Kirschner R., Varga-Szemes A., Toth L., Simor T., Suranyi P., Ruzsics B., et al. Reinfarction-specific magnetic resonance imaging contrast agent. J Am Coll Cardiol 2010, 55(10, Supplement 1):A84.E795-A84.E795.
26. Kirschner R., Toth L., Varga-Szemes A., Simor T., Suranyi P., Kiss P., et al. Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR. J Cardiovasc Magn Reson 2010, 12(1):22.
27. Simor T., Suranyi P., Ruzsics B., Toth A., Toth L., Kiss P., et al. Percent infarct mapping for delayed contrast enhancement MR imaging to quantify myocardial viability by Gd(DTPA). J Magn Reson Imaging 2010, 32(4):859-868.
28. Braunwald E., Rutherford J.D. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 1986, 8(6):1467-1470.
29. Fishbein M., Meerbaum S., Rit J., Lando U., Kanmatsuse K., Mercier J., et al. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981, 101(5):593-600.